Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127154711 | 12715471 | 1 | I | 20160823 | 20160906 | 20160906 | EXP | US-ROCHE-1825345 | ROCHE | 69.00 | YR | M | Y | 124.30000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127154711 | 12715471 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | LAST TREATMENT DATE 02/JAN/2015 | U | 125085 | 1740 | MG | SOLUTION FOR INFUSION | ||||||
127154711 | 12715471 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1742 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1737 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1025 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1760 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1824 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | 1865 | MG | SOLUTION FOR INFUSION | |||||||
127154711 | 12715471 | 8 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | LAST TREATMENT DATE 02/JAN/2015 | U | 0 | 70.5 | MG | |||||||
127154711 | 12715471 | 9 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 70.5 | MG | ||||||||
127154711 | 12715471 | 10 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 14 | MG | ||||||||
127154711 | 12715471 | 11 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 70.5 | MG | ||||||||
127154711 | 12715471 | 12 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 70.5 | MG | ||||||||
127154711 | 12715471 | 13 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 72 | MG | ||||||||
127154711 | 12715471 | 14 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | U | 0 | 72.6 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127154711 | 12715471 | 1 | Clear cell renal cell carcinoma |
127154711 | 12715471 | 8 | Clear cell renal cell carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127154711 | 12715471 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127154711 | 12715471 | Acute kidney injury | |
127154711 | 12715471 | Alanine aminotransferase increased | |
127154711 | 12715471 | Aspartate aminotransferase increased | |
127154711 | 12715471 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127154711 | 12715471 | 1 | 20140331 | 0 | ||
127154711 | 12715471 | 2 | 20140421 | 0 | ||
127154711 | 12715471 | 3 | 20140623 | 0 | ||
127154711 | 12715471 | 4 | 20140714 | 0 | ||
127154711 | 12715471 | 5 | 20140811 | 0 | ||
127154711 | 12715471 | 6 | 20141002 | 0 | ||
127154711 | 12715471 | 7 | 20141030 | 0 | ||
127154711 | 12715471 | 8 | 20140331 | 0 | ||
127154711 | 12715471 | 9 | 20140421 | 0 | ||
127154711 | 12715471 | 10 | 20140623 | 0 | ||
127154711 | 12715471 | 11 | 20140714 | 0 | ||
127154711 | 12715471 | 12 | 20140811 | 0 | ||
127154711 | 12715471 | 13 | 20141002 | 0 | ||
127154711 | 12715471 | 14 | 20141030 | 0 |